Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study

Study Overview
=================
Brief Summary
-----------------
This series aims at studying the peripapillary and macular vascular changes in subjects with unilateral anterior ischemic optic neuropathy via Optical Coherence Tomography Angiography (OCTA).

Detailed Description
-----------------
After approval of the local institutional ethics committee and local institutional review board, This study was conducted upon 30 patients diagnosed with acute NAION attending at Ophthalmology outpatient clinic in Fayoum University Hospitals. The participants were informed about the objectives of the study, the examination, investigations and the confidentiality of their information and their right not to participate in the study. OCT and OCTA was done for all subjects and control group with Optovue, Inc., Fremont, CA, USA. Patients were examined on presentation, after 6 weeks and lastly after 3 months. OCT was used for evaluation of Central macular thickness (CMT), nerve fiber layer thickness (NFLT) and ganglion cell complex (GCC). OCTA was done for quantitative evaluation of vessel density in the following: optic nerve head and peripapillary area, macular superficial vessel density, macular deep vessel density and foveal avascular zone. Vessel density was reported as the percentage of the total area that was occupied by blood vessels. All parameters were calculated automatically by the machine software. Poor quality scans and those with motion artifacts were excluded. Statistical analysis was performed using SPSS software (version 22; SPSS, Chicago, IL, USA). The data were presented as the mean ± SD values. P-value <0.05 was considered significant.

Official Title
-----------------
Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study

Conditions
-----------------
Non-arteritic Ischemic Optic Neuropathy

Intervention / Treatment
-----------------
* Diagnostic Test: Optical Coherence Tomography Angiography


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients diagnosed with unilateral NAION and acute or sudden painless drop of vision. A normal fellow eye. Age ≥ 40 years old. Exclusion Criteria: Arteritic type of AION. NAION patients in chronic phase. Acute phase NAION patients with any other optic neuropathy in the other eye. Eyes with opaque media. Elevated intraocular pressure (>22 mmHg). Refractive errors greater than 6 diopters of spherical equivalent. Poor cooperation with fixation or the OCTA examination.

Ages Eligible for Study
-----------------
Maximum Age: 40 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Diseased eyes<br>The 30 diseased eyes of the patients were considered the case group. | Diagnostic Test: Optical Coherence Tomography Angiography<br>* Optovue, Inc., Fremont, CA, USA<br>|
| Fellow eyes<br>The 30 fellow eyes of the patients were considered the control group. | Diagnostic Test: Optical Coherence Tomography Angiography<br>* Optovue, Inc., Fremont, CA, USA<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Peripapillary and macular vascular changes | comparing vessel density in different areas and sectors of diseased and fellow eyes | 3 months (0,6,12 weeks) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Thickness of different retinal layers | comparing thickness of Central macular thickness (CMT), nerve fiber layer thickness (NFLT) and ganglion cell complex (GCC) | 3 months (0,6,12 weeks) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
OCTA AION NAION